ABVX

#898
Abivax SA American Depositary Shares
125.80 USD
+3.70%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
125.80
125.80
Jahresspanne
5.59
148.83
Tagesänderung
+3.70%
Monatliche Änderung
+4.83%
6 month change
+28.09%
Jahresänderung
+2017.85%
Vorheriger Schlusskurs
121.31
Eröffnung
125.80
Bid
Ask
Tief
125.80
High
125.80
Volumen
48
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert 202320242025 TTM

Abivax SA - American Depositary Shares

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France.

Nachrichten